Johnson & Johnson Q2 2026 Earnings
Adj EPS $2.90 (est $2.85) -Sales $25.31B (est 25.04B) -Medtech Sales $8.93b (est $8.99b) -Medicine Revenue $16.38b (est $16.12b) -Sees FY Sales $100.88 To $101.48, Saw $100.3b To $101.3b -Sees FY Adj EPS $11.60 To $11.75, Saw $11.45 To $11.65 Sees FY Sales $100.8b To $101.4b, Saw $100.3b To $101.3b
Story updates
10:36:33 AM UTC
SquawkNews
Johnson & Johnson Q2 2026 Earnings
Adj EPS $2.90 (est $2.85) -Sales $25.31B (est 25.04B) -Medtech Sales $8.93b (est $8.99b) -Medicine Revenue $16.38b (est $16.12b) -Sees FY Sales $100.88 To $101.48, Saw $100.3b To $101.3b -Sees FY Adj EPS $11.60 To $11.75, Saw $11.45 To $11.65 Sees FY Sales $100.8b To $101.4b, Saw $100.3b To $101.3b